Jeffrey Wojton
Affiliations: | Ohio State University, Columbus, Columbus, OH |
Google:
"Jeffrey Wojton"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Robeson AC, Lindblom KR, Wojton J, et al. (2018) Dimer-specific immunoprecipitation of active caspase-2 identifies TRAF proteins as novel activators. The Embo Journal |
| Jaime-Ramirez AC, Dmitrieva N, Yoo JY, et al. (2017) Humanized Chondroitinase ABC Sensitizes Glioblastoma Cells to Temozolomide. The Journal of Gene Medicine |
| Bolyard CM, Meisen WH, Banasavadi-Siddegowda Y, et al. (2016) BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection- implications for Oncolytic Viral Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Yoo JY, Jaime-Ramirez AC, Bolyard C, et al. (2016) Bortezomib treatment sensitizes oncolytic HSV-1 treated tumors to NK cell immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Wojton J, Meisen WH, Kaur B. (2015) How to train glioma cells to die: molecular challenges in cell death. Journal of Neuro-Oncology |
| Huang B, Yang CS, Wojton J, et al. (2014) Metabolic control of Ca2+/calmodulin-dependent protein kinase II (CaMKII)-mediated caspase-2 suppression by the B55β/protein phosphatase 2A (PP2A). The Journal of Biological Chemistry. 289: 35882-90 |
| Wojton J, Meisen WH, Jacob NK, et al. (2014) SapC-DOPS-induced lysosomal cell death synergizes with TMZ in glioblastoma. Oncotarget. 5: 9703-9 |
| Van Brocklyn JR, Wojton J, Meisen WH, et al. (2014) Aurora-A inhibition offers a novel therapy effective against intracranial glioblastoma. Cancer Research. 74: 5364-70 |
| Wojton J, Elder J, Kaur B. (2014) How efficient are autophagy inhibitors as treatment for glioblastoma? Cns Oncology. 3: 5-7 |
| Yan F, Alinari L, Lustberg ME, et al. (2014) Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma. Cancer Research. 74: 1752-65 |